Amal Taher Elhaw
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Amal Taher Elhaw has a total of 113 co-authors. Here are the top co-authors by number of shared publications:
- Nadine Hempel
UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine
44 shared publications - Katherine M. Aird
Molecular and Cellular Oncogenesis Program, Ellen and Ronald Caplan Cancer Center, The Wistar Institute, Philadelphia, PA, USA
34 shared publications - Karthikeyan Mythreye
University of Alabama Birmingham
33 shared publications - Shriya Kamlapurkar
UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
33 shared publications - Ya-Yun Cheng
UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
33 shared publications - Zaineb Javed
UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
33 shared publications
Latest Publications
- Open Access
- 30 July 2026
- Published by Springer Nature in Nature Aging
- Vol. 6 (8) , 1647-1666
The chemotherapy-induced senescence-associated secretome promotes cell detachment and metastatic dissemination through metabolic reprogramming
- 30 July 2026
- Published by Springer Nature in Nature Aging
- Vol. 6 (8) , 1647-1666
Open AccessThe chemotherapy-induced senescence-associated secretome promotes cell detachment and metastatic dissemination through metabolic reprogramming
- Open Access
- 1 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S10 from RHOV Is a Detachment-Responsive Rho GTPase Necessary for Ovarian Cancer Peritoneal Metastasis
RHOV regulated transcriptional pathways
- 1 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S10 from RHOV Is a Detachment-Responsive Rho GTPase Necessary for Ovarian Cancer Peritoneal Metastasis
RHOV regulated transcriptional pathways
- Open Access
- 1 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S9 from RHOV Is a Detachment-Responsive Rho GTPase Necessary for Ovarian Cancer Peritoneal Metastasis
Validation of spheroid compaction, mesothelial adhesion and migration defects following RHOV depletion.
- 1 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S9 from RHOV Is a Detachment-Responsive Rho GTPase Necessary for Ovarian Cancer Peritoneal Metastasis
Validation of spheroid compaction, mesothelial adhesion and migration defects following RHOV depletion.
- Open Access
- 1 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S7 from RHOV Is a Detachment-Responsive Rho GTPase Necessary for Ovarian Cancer Peritoneal Metastasis
RHOV KO in adherent conditions
- 1 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S7 from RHOV Is a Detachment-Responsive Rho GTPase Necessary for Ovarian Cancer Peritoneal Metastasis
RHOV KO in adherent conditions